Chief Commercial Officer Sells $1.93 Million in Company Stock
HLF has more than doubled off its 52-week low of $6.62.
Summary
Herbalife's Chief Commercial Officer, Frank Lamberti, sold $1.93 million in company stock, reducing his direct holdings.
Key Events · Ownership and Investor Activity · HLF
-
Chief Commercial Officer Sells Shares
Frank Lamberti, Chief Commercial Officer, disposed of 142,919 shares of common stock in open market sales for a total value of $1,932,259.
-
Significant Insider Disposition
The sale represents a notable transaction from a C-suite executive, occurring between May 11 and May 12, 2026, at prices ranging from $13.50 to $13.86 per share.
-
Reduced Holdings
Following these transactions, Mr. Lamberti's direct holdings in Herbalife Ltd. common stock are 36,624 shares.
-
Context of Recent Positive News
This insider sale follows recent positive announcements from Herbalife, including robust Q1 2026 financial results, raised full-year outlook, and a successful $1.45 billion debt refinancing.
Analysis · HLF · Trade & Services
Frank Lamberti, Herbalife's Chief Commercial Officer, sold approximately $1.93 million worth of company stock. This is a notable disposition from a C-suite executive, especially following a period of positive company news including strong Q1 results and a successful debt refinancing. While it could be profit-taking, a significant insider sale can be viewed negatively by investors.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 29.5% of the 1672 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.22%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HLF was trading at $13.63 on NYSE in the Trade & Services sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $6.62 to $20.40. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.